Home/Filings/4/0001179110-12-012302
4//SEC Filing

GEN PROBE INC 4

Accession 0001179110-12-012302

CIK 0000820237operating

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:43 PM ET

Size

23.4 KB

Accession

0001179110-12-012302

Insider Transaction Report

Form 4
Period: 2012-08-01
Jorgine Ellerbrock
Senior VP Operations
Transactions
  • Disposition to Issuer

    Common Stock

    2012-08-01$82.75/sh4,783$395,7930 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$18.95/sh24,141$457,4720 total
    Exercise: $63.80Exp: 2018-02-10Common Stock (24,141 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-0124,8920 total
    Exercise: $69.22Exp: 2019-02-10Common Stock (24,892 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$40.09/sh18,192$729,3170 total
    Exercise: $42.66Exp: 2017-02-10Common Stock (18,192 underlying)
  • Disposition to Issuer

    Performance Stock Rights

    2012-08-0110,2080 total
    Exercise: $0.00Exp: 2015-02-10Common Stock (10,208 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$22.60/sh14,000$316,4000 total
    Exercise: $60.15Exp: 2015-08-15Common Stock (14,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$17.38/sh25,000$434,5000 total
    Exercise: $65.37Exp: 2014-12-03Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$44.24/sh6,992$309,3260 total
    Exercise: $38.51Exp: 2016-08-17Common Stock (6,992 underlying)
  • Disposition to Issuer

    Performance Stock Rights

    2012-08-012,7430 total
    Exercise: $0.00Exp: 2014-02-10Common Stock (2,743 underlying)
Footnotes (6)
  • [F1]The amount reported includes an aggregate of 74 shares of common stock acquired under the Registrant's Employee Stock Purchase Plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
  • [F2]This stock option was canceled pursuant to the Agreement and Plan of Merger, dated as of April 29, 2012, by and among the Registrant, Hologic, Inc. ("Hologic"), and Gold Acquisition Corp. (the "Merger Agreement"), in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) the excess of $82.75 (the per share merger consideration pursuant to the Merger Agreement) over the exercise price of the stock option; and (ii) the number of shares of common stock of the Registrant underlying the stock option.
  • [F3]25% of the shares subject to the stock option vest on February 10, 2013, and the remaining shares vest in equal monthly installments over the following three years.
  • [F4]Pursuant to the Merger Agreement, these options were assumed by Hologic and converted into options to acquire that number of shares of Hologic common stock which is equal to the number of shares of common stock of the Registrant subject to such options immediately prior to the merger multiplied by 4.51174963 with a per share exercise price equal to the quotient determined by dividing the per share exercise price of such options immediately prior to the merger by 4.51174963.
  • [F5]The performance stock rights were canceled pursuant to the Merger Agreement and converted into the right to receive a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) $82.75 (the per share merger consideration pursuant to the Merger Agreement); and (ii) 4,114 (which amount equals 150% of the target number of shares of common stock of the Registrant underlying the performance stock rights).
  • [F6]The performance stock rights were canceled pursuant to the Merger Agreement and converted into the right to receive a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) $82.75 (the per share merger consideration pursuant to the Merger Agreement); and (ii) 7,656 (which amount equals 150% of the target number of shares of common stock of the Registrant underlying the performance stock rights).

Issuer

GEN PROBE INC

CIK 0000820237

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000820237

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:43 PM ET
Size
23.4 KB